Steven CPA - Ginkgo Bioworks Chief Officer
| DNA Stock | USD 0.89 0 0.34% |
Executive
Steven CPA is Chief Officer of Ginkgo Bioworks Holdings
| Address | 27 Drydock Avenue, Boston, MA, United States, 02210 |
| Phone | 877 422 5362 |
| Web | https://www.ginkgobioworks.com |
Ginkgo Bioworks Management Efficiency
The company has Return on Asset of (0.2182) % which means that on every $100 spent on assets, it lost $0.2182. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.6302) %, meaning that it generated no profit with money invested by stockholders. Ginkgo Bioworks' management efficiency ratios could be used to measure how well Ginkgo Bioworks manages its routine affairs as well as how well it operates its assets and liabilities. As of May 9, 2024, Return On Tangible Assets is expected to decline to -0.61. In addition to that, Return On Capital Employed is expected to decline to -0.47. At present, Ginkgo Bioworks' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 107.1 M, whereas Net Tangible Assets are forecasted to decline to about 1.1 B.Similar Executives
| Found 14 records | EXECUTIVE Age | ||
| Patrick Mayo | Hepion Pharmaceuticals | N/A | |
| Kirsten Dupuis | AVROBIO | N/A | |
| Candice Masse | Elevation Oncology | N/A | |
| Daniel Trepanier | Hepion Pharmaceuticals | N/A | |
| Steven JD | AVROBIO | 62 | |
| John SullivanBolyai | Hepion Pharmaceuticals | 76 | |
| MD MBA | Ocean Biomedical | 59 | |
| Kevin CPA | Enveric Biosciences | 60 | |
| Scott Gottesman | AVROBIO | N/A | |
| John Cavan | Hepion Pharmaceuticals | 66 | |
| Esq CPA | Ocean Biomedical | 59 | |
| Andreas Kouri | AVROBIO | N/A | |
| Robert Yang | Elevation Oncology | N/A | |
| Robert Sweeney | Ocean Biomedical | 59 | |
Management Performance
| Return On Equity | -0.63 | ||||
| Return On Asset | -0.22 |
Ginkgo Bioworks Holdings Leadership Team
Elected by the shareholders, the Ginkgo Bioworks' board of directors comprises two types of representatives: Ginkgo Bioworks inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ginkgo. The board's role is to monitor Ginkgo Bioworks' management team and ensure that shareholders' interests are well served. Ginkgo Bioworks' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ginkgo Bioworks' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Anna Wagner, Senior Development | ||
| Karen Tepichin, General Secretary | ||
| Steven CPA, Chief Officer | ||
| Jason Kelly, CEO Founder | ||
| Samantha Sutton, Head People | ||
| Mark Dmytruk, Chief Officer | ||
| Reshma Shetty, President, Founder | ||
| Joshua Dunn, Head Design | ||
| Thomas Knight, Founder | ||
| Marie Fallon, Chief Officer | ||
| Bartholomew Canton, CTO Founder | ||
| Austin Che, Head Founder |
Ginkgo Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Ginkgo Bioworks a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.63 | ||||
| Return On Asset | -0.22 | ||||
| Operating Margin | (5.16) % | ||||
| Current Valuation | 1.09 B | ||||
| Shares Outstanding | 1.7 B | ||||
| Shares Owned By Insiders | 6.55 % | ||||
| Shares Owned By Institutions | 80.28 % | ||||
| Number Of Shares Shorted | 266.53 M | ||||
| Price To Earning | 25.51 X | ||||
| Price To Book | 1.98 X |
Pair Trading with Ginkgo Bioworks
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ginkgo Bioworks position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ginkgo Bioworks will appreciate offsetting losses from the drop in the long position's value.Moving against Ginkgo Stock
| 0.63 | VRCA | Verrica Pharmaceuticals Financial Report 14th of May 2024 | PairCorr |
| 0.6 | HOOK | Hookipa Pharma | PairCorr |
| 0.55 | ELYM | Eliem Therapeutics | PairCorr |
| 0.43 | HCWB | HCW Biologics | PairCorr |
| 0.41 | VIRI | Virios Therapeutics Llc | PairCorr |
The ability to find closely correlated positions to Ginkgo Bioworks could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ginkgo Bioworks when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ginkgo Bioworks - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ginkgo Bioworks Holdings to buy it.
The correlation of Ginkgo Bioworks is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ginkgo Bioworks moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ginkgo Bioworks Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ginkgo Bioworks can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Ginkgo Bioworks Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Complementary Tools for Ginkgo Stock analysis
When running Ginkgo Bioworks' price analysis, check to measure Ginkgo Bioworks' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ginkgo Bioworks is operating at the current time. Most of Ginkgo Bioworks' value examination focuses on studying past and present price action to predict the probability of Ginkgo Bioworks' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ginkgo Bioworks' price. Additionally, you may evaluate how the addition of Ginkgo Bioworks to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
Is Ginkgo Bioworks' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ginkgo Bioworks. If investors know Ginkgo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ginkgo Bioworks listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.46) | Revenue Per Share 0.129 | Quarterly Revenue Growth (0.65) | Return On Assets (0.22) | Return On Equity (0.63) |
The market value of Ginkgo Bioworks Holdings is measured differently than its book value, which is the value of Ginkgo that is recorded on the company's balance sheet. Investors also form their own opinion of Ginkgo Bioworks' value that differs from its market value or its book value, called intrinsic value, which is Ginkgo Bioworks' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ginkgo Bioworks' market value can be influenced by many factors that don't directly affect Ginkgo Bioworks' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ginkgo Bioworks' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ginkgo Bioworks is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ginkgo Bioworks' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.